Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPITOX: Botulinum Toxin and Corticoid for Lateral Epicondylitis
NCT03380559Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2019
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Lateral Epicondylitis (LET), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT03380559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380559.